2026-01-29 - Analysis Report
**Company Overview**: Ventas Inc. is a healthcare real estate investment trust (REIT) that invests in and owns a diversified portfolio of medical office buildings, senior housing, and health care facilities.

**Section 1: Return Rate Comparison**

* Ticker: VTR
* Cumulative return of review stock: **71.70%**
* Cumulative return of comparison stock (S&P 500, VOO): **128.51%**
* Divergence (max: 20.60, min: -87.80, current: -56.70, relative divergence: 28.70%)

The review stock, Ventas Inc. (VTR), has underperformed the comparison stock (S&P 500, VOO) with a cumulative return of 71.70% vs. 128.51%. The divergence is -56.70, indicating the review stock's underperformance.

**Section 2: Recent Stock Price Fluctuations**

* Close: $75.92
* Last-market change: -0.04%
* 5-day SMA: $76.34
* 20-day SMA: $76.72
* 60-day SMA: $77.86

The review stock's price has been relatively stable with a slight decline of -0.04%. The moving averages (MA) are still above the current price, indicating a potential rebound.

**Section 3: Analysis of RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* RSI: 51.48
* PPO: -0.10
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: -10.00 (-): worsening
* 7-day Rank change: -105 (-): rank down
* 7-day Dynamic Expected Return change: -131.50 (-): worsening
* Expected Return (%): -135.00%

The review stock's RSI and PPO indicators are showing a bearish trend. The Market Risk Indicator (MRI) is at 0.70, indicating a medium-risk investment. The Expected Return is -135.00%, indicating a potential decline in the short-term.

**Section 4: Recent News & Significant Events**

* [2026-01-25] Y Intercept Hong Kong Ltd Raises Stock Position in Ventas, Inc. $VTR - MarketBeat (news.google.com)
* [2026-01-26] Does Ventasâ€™ EPS Surge And Uptrend Signal A Stronger Long-Term Thesis For VTR? - simplywall.st (news.google.com)
* [2026-01-24] Ventas Inc (NYSE:VTR) Emerges as a High-Growth Momentum Candidate After Sideways Consolidation - Chartmill (news.google.com)
* [2026-01-26] (VTR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily (news.google.com)
* [2025-10-23] Is Ventas (VTR) The Best REIT Dividend Stock to Buy for Non-AI Trade? - Yahoo Finance (news.google.com)
* [2026-01-08] VTR Stock Falls -5.2% With 7-day Losing Spree On C-Suite Stock Sales - Trefis (news.google.com)

These recent news articles suggest that Ventas Inc. has been attracting investors and may have a strong long-term thesis. However, recent C-Suite stock sales have led to a decline in the stock price.

**Section 4-2: Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.52 (~Buy)
- Opinions: 20
- Target Price (avg/high/low): 85.90 / 94.00 / 75.00

Analysts are generally bullish on Ventas Inc., with a mean rating of 1.52 (Strong Buy) and a target price range of $75.00 to $94.00.

**Section 5: Recent Earnings Analysis**

| Date | EPS | Revenue |
|-----|----|---------|
| 2025-10-30 | 0.14 | 1.49 B$ |
| 2025-07-31 | 0.15 | 1.42 B$ |
| 2025-05-01 | 0.11 | 1.36 B$ |
| 2024-10-31 | 0.05 | 1.24 B$ |

The review stock's earnings per share (EPS) have been relatively stable, ranging from $0.05 to $0.15. Revenue has also been relatively stable, ranging from 1.24 B$ to 1.49 B$.

**Section 6: Financial Information**

Revenue and Profitability:

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.49B | 41.58% |
| 2025-06-30 | $1.42B | 41.80% |
| 2025-03-31 | $1.36B | 42.15% |
| 2024-12-31 | $1.29B | 42.42% |
| 2024-09-30 | $1.24B | 42.17% |

Capital and Profitability:

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $12.36B | 0.53% |
| 2025-06-30 | $11.53B | 0.59% |
| 2025-03-31 | $11.47B | 0.41% |
| 2024-12-31 | $10.77B | 0.53% |
| 2024-09-30 | $9.76B | 0.20% |

The review stock's revenue and profit margin have been relatively stable, ranging from 41.58% to 42.42%. Equity has been increasing, ranging from $9.76 B to $12.36 B. However, Return on Equity (ROE) has been relatively low, ranging from 0.20% to 0.59%.

**Section 7: Comprehensive Analysis**

Overall, the review stock, Ventas Inc. (VTR), has underperformed the comparison stock (S&P 500, VOO) with a cumulative return of 71.70% vs. 128.51%. The review stock's RSI and PPO indicators are showing a bearish trend. The Market Risk Indicator (MRI) is at 0.70, indicating a medium-risk investment. Recent news articles suggest that Ventas Inc. has been attracting investors and may have a strong long-term thesis. However, recent C-Suite stock sales have led to a decline in the stock price. Analysts are generally bullish on Ventas Inc., with a mean rating of 1.52 (Strong Buy) and a target price range of $75.00 to $94.00. However, the review stock's earnings per share (EPS) and revenue have been relatively stable, ranging from $0.05 to $0.15 and 1.24 B$ to 1.49 B$, respectively. Equity has been increasing, ranging from $9.76 B to $12.36 B. However, Return on Equity (ROE) has been relatively low, ranging from 0.20% to 0.59%. Overall, the review stock's performance is mixed, with both positive and negative trends.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.